The first paper describing the modern era of EECP is published by Dr’s. Lawson, Soroff, Zheng and Hui using the term EECP. It marks the first instance the MC2 device is identified to describe the
enhanced features of external counter-pulsation exclusively manufactured and trademarked
by Vasomedical.
This event precedes the publication of over 190 articles, the majority of which are published in major peer-reviewed medical journals – all similarly identifying the MC2 device.